GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark is the first to launch Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India03-01-2024
03-01-2024
Glenmark Pharma shares trade flat as Nirma to acquire majority stake in Glenmark Life
In September this year, Glenmark Pharmaceuticals said its board has approved to divest 75 per cent stake in its subsidiary GLS.20-12-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Minutes Of The Resolution Passed By Way Of Postal Ballot Through Remote E-Voting
Enclosing the minutes of the resolution passed by Postal Ballot30-11-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
The transcript of the Earnings Call held on Wednesday, November 15, 2023 for the second quarter and half year ended September 30, 2023 has been uploaded on the Company''s website.20-11-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor Meetings16-11-2023
Glenmark Pharmaceuticals Share Price Live blog for 16 Nov 2023
Glenmark Pharmaceuticals stock price went up today, 16 Nov 2023, by 3.6 %. The stock closed at 724.55 per share. The stock is currently trading at 750.6 per share. Investors should monitor Glenmark Pharmaceuticals stock price closely in the coming days and weeks to see how it reacts to the news.16-11-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of Q2 FY 2023-24 Earnings Call held on 15th November, 2023 on the website of the Company.15-11-2023
Glenmark Pharmaceuticals Share Price Live blog for 13 Nov 2023
Glenmark Pharmaceuticals stock price went down today, 13 Nov 2023, by -1.27 %. The stock closed at 777.6 per share. The stock is currently trading at 767.75 per share. Investors should monitor Glenmark Pharmaceuticals stock price closely in the coming days and weeks to see how it reacts to the news.13-11-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation Q2 FY 23-2410-11-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release and Management Discussion & Analysis10-11-2023